AC

Alex Crisses

Managing Director at General Atlantic

New York, New York

Invests in

Stages:

  • Min Investment:

    $20,000,000.00
  • Max Investment:

    $100,000,000.00
  • Target Investment:

    $25,000,000.00

Skills

Start-ups
Management
Business Strategy
Strategic Partnerships
Entrepreneurship
Venture Capital
Strategy
Business Development
Mergers & Acquisitions
Due Diligence

Education

Work Experience

  • Managing Director

    2016

    General Atlantic is a leading global growth equity firm providing capital and strategic support for growth companies. Established in 1980, General Atlantic combines a collaborative global approach, sector-specific expertise, long-term investment horizon, and a deep understanding of growth drivers to partner with great management and build exceptional businesses worldwide. Helping growing businesses rise to new heights is our purpose and our passion. Drawing from over three decades of experience investing in 250 growth companies, we focus exclusively on partnering with exceptional companies that have proven business models and strong revenue growth in dynamic industries. General Atlantic has more than 100 investment professionals based in New York, Greenwich, Palo Alto, Sao Paulo, Mexico City, London, Munich, Amsterdam, Beijing, Hong Kong, Mumbai, and Singapore. Our firm was founded as a family office for a single entrepreneur who enlisted our team to help fellow entrepreneurs build great companies and enable others to invest in innovation and growth. Today, we remain true to our original mission. We are committed to helping high-quality companies achieve unprecedented, long-term success. Alex Crisses is a Managing Director at General Atlantic, based in the firm’s New York office. He serves on the board of Synaptive Medical as an observer. Prior to joining GA in 2016, Alex was a Managing Director at Insight Venture Partners. Before joining Insight, he worked in investment banking at Credit Suisse, with a focus on energy and power. At Insight, he was an active participant in several of the firm’s investments, serving as a director or board observer of 6Waves/LOLapps, Alteryx, Anaqua, Cvent (NYSE:CVT), Flipp, Frontline Technologies, GFI Software, Imceda, Jagex Limited, Mirantis, New Relic (NYSE:NEWR), ScriptLogic, Solarwinds (NYSE: SWI), TeamViewer, TicketMonster, Tintri, Wix (NASDAQ:WIX), and Xamarin.

2021

  • Board Member

    2021

2021

  • Board Member

    2021

2021

  • Board Member

    2021

  • Board Member

    2020

  • Board Member

    2019

  • Board Member

    2018

    Benevity is the global leader in online workplace giving, matching, volunteering and integrated grant management solutions. Some of the world’s most iconic brands rely on Benevity’s award-winning solutions to power their Goodness Programs and corporate philanthropy, helping them attract, retain and engage today’s workers by connecting people personally to causes that matter to them. With almost 2 million users around the world, Benevity will process donations for more than 100,000 global charities this year. As a certified B Corporation, Benevity is part of a unique breed of for-profit companies with a social mission who believe that ‘doing well by doing good’ is more than just a catchy tagline.

2017

  • Board Member

    2017

    Gympass is a discovery platform that helps employees of corporate partners find an activity to love. Presented as a corporate benefit with a flexible rolling monthly contract, Gympass partners with companies to provide unlimited access to a global network of wellness providers for their employees at a subsidy of up to 70% off market prices. Based in New York, Gympass is active in 13 countries across the world and engages over 30,000 fitness facilities within nearly 5,000 cities. Gympass is headquartered in New York City and has four additional U.S. offices in Chicago, Atlanta, Houston and Los Angeles, with 100 employees across the nation and 800 employees across 10 global cities: Sao Paulo, Mexico City, Buenos Aires, Santiago, Madrid, Paris, Munich, Amsterdam, London, Milan and 2 remote offices in Portugal and Ireland.

  • Board Observer

    2017

  • Pediatrics Council - Board Member

    2014

    Best Hospital, Best Results HSS is nationally ranked No. 1 in orthopedics, and No. 2 in rheumatology by U.S.News & World Report (2016-17). HSS has been top-ranked for both orthopedics and rheumatology for 25 consecutive years. Because an infection can be a devastating outcome for an orthopedic patient, Hospital for Special Surgery takes infection control extremely seriously and is proud of the recognition received for our significantly low infection rates. HSS and a complement of physicians within each specialty area accepts most major insurance plans. Our Insurance Advisory Service can answer questions regarding your insurance coverage. Learn more about why you should entrust HSS with your care. Unmatched Experience Founded in 1863, Hospital for Special Surgery is the nation’s oldest orthopedic hospital. More than 29,000 surgical procedures are performed annually. HSS performs more hip surgeries and more knee replacements than any other hospital in the nation. HSS surgeons who specialize in joint replacement perform, on average, 365 of these operations every year. Compare our volumes to other hospitals.